Peter Kuhn, PhD
Associate Professor, Department of Cell and Molecular Biology
The Scripps Research Institute, La Jolla, California
2013-2014 BCRF Project:
Patients with breast cancer would benefit significantly from precise characterization of their disease at multiple time points throughout the course of the disease. This can be accomplished by utilizing a simple blood draw as a fluid biopsy. This fluid biopsy can be used to identify rare circulating tumor cells (CTCs) and also circulating genomic fragments that together provide the opportunity for a complete description of the disease. This project, led by Drs. Kuhn and Hicks, develops and applies the next generation technology to provide this data to the physician to aid in treatment decisions.
Dr. Peter Kuhn received his doctorate in Physics from State University of New York, Albany.
He is currently Associate Professor in the Department of Cell and Molecular Biology at The Scripps Research Institute. Dr. Kuhn’s laboratory has developed a reliable way to detect and to characterize CTCs isolated from the blood of cancer patients. His research is focused on the development of a fluid biopsy for the diagnosis, prognosis and therapy management of breast, lung, colon, prostate and other tissue cancers.
Dr. Kuhn is the principal investigator of the National Cancer Institute’s Physics Oncology Center on the 4-dimensional biopsy to study the physics and mathematics of cancer metastasis. Finding and characterizing these cells early provides a new opportunity to monitor and characterize the cancer over time and tailor the treatment to the specifics of an individual’s cancer.